window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

digital mental health

  • Central Nervous System,Clinical & Regulatory,Digital & Data,Pharmaceuticals and therapeutics,Therapeutic Areas

    Limbic selected for FDA pilot to test AI-led mental healthcare

    Limbic has been selected for the US Food and Drug [...]

    August 19, 2026
  • Clinical & Regulatory,Digital & Data,Therapeutic Areas

    Grow Therapy study finds most patients report meaningful improvement in depression and anxiety symptoms

    Grow Therapy has published its first peer-reviewed outcomes study, reporting [...]

    May 14, 2026
  • Biotech & Pharma Business,Digital & Data,Opinion & Events,Therapeutic Areas

    Wellcome awards £5.3m grant to Wysa for adolescent mental health study in India

    Wellcome has awarded £5.3m in funding to digital mental health [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Wiley launches spectral analysis APIs for faster compound identification
    Categories: Digital & Data, Drug Discovery & Development, Research & Development
  • Pusan National University study links stress signalling to immune escape in cold tumours
    Categories: Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Hansa Biopharma treats first commercial kidney transplant patient with Idefirix in Australia
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top